Background Tuberculosis (TB) is the world's leading infectious cause of death.
Extrapulmonary TB accounts for 15% of TB cases, but the proportion is increasing, and over …

Background Xpert MTB/RIF Ultra (Xpert Ultra) and Xpert MTB/RIF are World Health
Organization (WHO)‐recommended rapid nucleic acid amplification tests (NAATs) widely …

Objective We compared diagnostic accuracy of pleural fluid Xpert MTB/RIF (Xpert) and Xpert
MTB/RIF Ultra (Ultra) assays for diagnosing tuberculous pleural effusion (TPE), through …

Background We performed a meta-analysis to determine diagnostic accuracy of Xpert
MTB/RIF for diagnosis of abdominal (intestinal or peritoneal) tuberculosis (TB) in various …

Objectives The diagnosis of extrapulmonary tuberculosis (EPTB) is often made on clinical
suspicion alone, resulting in both under-and overdiagnosis and relatively poor outcomes. In …

Diagnostic accuracy of Xpert MTB/RIF assay for pulmonary tuberculosis (PTB) and
extrapulmonary TB (EPTB) has not been investigated in Iran. This study was aimed to …

Objectives. To evaluate the performance of Xpert MTB/RIF for lymph node tuberculosis
(LNTB). Methods. We searched databases for published reports. We reviewed the studies …

Early diagnosis of spinal tuberculosis (TB) is hampered by the flaws of conventional tests.
The aim of this study was to assess the value of new and existing molecular tests in a …

Background: Extrapulmonary Tuberculosis (EPTB) accounts for 15%–53% of all TB cases. In
recent years, cartridge-based nucleic acid amplification test (CBNAAT) has emerged as an …

The purpose of this study was to determine the diagnostic efficacy of Xpert MTB/RIF assay
for rapid diagnosis of Tuberculosis (TB) and detection of rifampicin (RIF) resistance in …